| Added by | mollevi |
|---|---|
| Group name | EquipePC |
| Item Type | Note |
| Note | The following values have no corresponding Zotero field: auth-address: Medical Oncology Clinic, Institut Jules Bordet, Universite Libre de Bruxelles, Brussels, Belgium. Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Universite Libre de Bruxelles, Brussels, Belgium. Breast International Group (BIG aisbl), Brussels, Belgium. Department of Radiology, Institut Jules Bordet, Universite Libre de Bruxelles, Brussels, Belgium. Medigene AG, Planegg, Germany. Department of Biostatistics, Institut Jules Bordet, Universite Libre de Bruxelles, Brussels, Belgium. Department of Surgery, Institut Jules Bordet, Universite Libre de Bruxelles, Brussels, Belgium. Service de Biostatistique et d'Epidemiologie, Gustave Roussy, Univ. Paris-Sud, Villejuif, France. Department of Pathology, Institut Jules Bordet, Universite Libre de Bruxelles, Brussels, Belgium. alt-title: PloS one number: 7 accession-num: 27454930 |
| Tags | _EndnoteXML import |
| Date Added | 2018/11/14 - 12:07:50 |
| Date Modified | 2018/11/14 - 12:07:50 |
| Parent item | Feasibility Study of EndoTAG-1, a Tumor Endothelial Targeting Agent, in Combination with Paclitaxel followed by FEC as Induction Therapy in HER2-Negative Breast Cancer |
Institut de Recherche en Cancérologie de
